Global Infertility Services Market Forecast, Trend Analysis and Competition Tracking - Global Industry insights 2015 to 2031

Infertility is a medical condition in which a woman is unable to get pregnant due to particular circumstances. Infertility is related to both women and men. In men, infertility refers to low sperm count, blockages, and abnormal sperm function that prevent sperm delivery. Women who can conceive but not carry pregnancy are also diagnosed with infertility. Both men and women are equally likely to be infertile. These issues of infertility are treated with infertility services to cure fertility and genetic problem related to conception. Fertility services include IVF (In vitro fertilization), IUI (Intrauterine insemination), intracytoplasmic sperm injection (ICSI), etc., to treat infertility.

Request Covid - 19 Impact

Moreover, the freezing of eggs or sperm has become a trend among new generation couples. While egg freezing has become a widespread consideration among women in their 30s, sperm freezing has gained momentum among couples. Egg freezing is a technique in which women's eggs are collected and frozen to be utilized in the future. Egg freezing has been in use for 30 years, but it recently gained popularity, especially amongst single women in their 20s and 30s. There has been a sharp decline in a woman's fertility in her mid-30s. As the trend for older motherhood continues, more and more women consider egg freezing as a form of "insurance" against age-related infertility. Likewise, sperm freezing also has become a trend among men in their mid-30s. More men are now considering choosing to freeze sperm to make sure that they can father healthy babies later in life.

The Prevalence of Infertility is High1

Global Infertility Services Market Revenue Outlook:

The global infertility services market is valued at US$ 52,207.9 Mn in 2021 and is projected to register а САGR of 6.4% by 2031.

The global infertility services market is segmented into infertility service type, gender type, end-user, and regions. The fertility service type segment includes diagnostic services, treatment services & fertility preservation. The treatment services segment accounts for the highest revenue share among the infertility service segments due to its increased adoption among couples facing genetic or other birth-related problems. Among the end-use segments, fertility clinics account for a significant share in terms of revenue. This is due to the decrease in fertility rate and safe conceiving procedures provided by clinics such as IVF, IUI, and others. Among the regional markets, the European market is expected to account for significant revenue share and is projected to maintain its dominance in the global infertility services market over the forecast period. This is due to the presence of advanced infertility services with a high percentage of success rate.

There are multiple reasons someone may seek fertility assistance

Source: American Society for Reproductive Medicine, Infertility. An overview. Patient Information Series 2020. WHO Technical Report Series. Recent Advances in Medically

Genetic Disorder Is the Leading Cause of Infertility in Both Men and Women

The genetic disorder is also a cause of infertility in both men and women. Genetic conditions such as cystic fibrosis gene mutation, Klinefelter syndrome, Y chromosome microdeletions of a gene, Noonan syndrome, & others cause infertility in men by compromising the mature production of sperm. Similarly, inherited chromosome abnormality, Kallmann syndrome, karyotype abnormalities, etc., cause infertility in women. The increase in the level of a genetic disorder in human beings has led to infertility services to conceive and reproduce naturally. These factors are liable for the market growth of the infertility service market in the coming years.

• A study by the National Institute of Health, USA, stated that genetic disorder causes 2- 8% of male infertility cases.
• According to various research studies, genetic abnormalities are present in almost 10% of infertile females and 15% of infertile males. Evidence suggests that chromosomal abnormalities and single-gene mutations contribute to infertility in a proportion of couples seeking infertility therapy.

Medical Devices for the IVF Cycle

Stringent Regulations May Hamper Market Growth

Several restrictions and laws related to infertility treatment and services are likely to hamper the market growth. Fertility treatment or services vary from country to country. Some of the fertility services and treatments are either banned or restricted to specific rules.

• There are regulatory differences concerning reimbursement, state funding, and embryo research. Most European countries have set a legal limit on the number of embryos transferred in a single cycle.
• Egg donation/ contribution is not allowed in Germany and Norway. In Germany, embryo freezing is only permitted in an emergency under embryo protection legislation but fully qualified for fertilized eggs at the stage 2PN (two pronuclei).
• Surrogacy is not allowed in Austria, Bulgaria, Finland, France, Germany, Hungary, Italy, Lithuania, Norway, Serbia, Slovakia, Slovenia, Spain, Sweden, Cambodia, Denmark, Ireland, and Portugal

Impact of COVID–19 on the market
The outbreak of COVID-19 had a negative impact on almost every industry. The medical sector also witnessed intense disruptions in the global supply chain of raw materials, transportation of end-products, delayed clinical trials, and disrupted processes worldwide. This had led to price fluctuations and sudden shortages of raw materials and end-products used in medical procedures. Moreover, medical travel is also primarily affected due to the pandemic as travel has been restricted to most countries. Also, the fear of getting infected has led to delay in foreign travel and medical procedures. Such factors can restrain inbound and outbound fertility services, thus, hamper the market's growth.

Favorable Reimbursement Policies Is Expected to Create Lucrative Opportunity for The Player
Reimbursement policies incorporated by government and private institutes have led to infertility treatments in various countries. Its success rate is low, and the high cost of the procedure has kept it out of reach from many individuals. Thus, introducing such policies is likely to increase the treatment adoption rate and is expected to create an opportunity for players in the market.

• In Germany, 4 IVF cycles are reimbursed by health insurance companies in patients up to 40 years of age
• In Greece, IVF treatment costs are reimbursed if performed in a public hospital.
• In Italy, hospitals and clinics operating within the national health service provide partial reimbursement for procedures.
• According to the National Infertility Association, As of August 2020, 19 states have passed fertility insurance coverage laws, 13 of those laws include IVF coverage, and ten states have fertility preservation laws for iatrogenic (medically-induced) infertility.

Competitive Landscape

The infertility services market landscape appears highly consolidated, with a significant chunk of it being dominated by players.

• Apollo Hospitals Enterprise Ltd
• Progyny Inc.
• Vitrolife AB
• Monash IVF Group Ltd
• Genea Limited
• Care Fertility Group Ltd
• Fertility Associates
• City Fertility
• Ovation Fertility
• Carolinas Fertility Institute
• Other Key Players

Report Scope

Forecast Period: 2022-2031
Actual Year: 2021
Historical Data Available for: 2015-2020

Key Regions Covered

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Segments Covered

Infertility Services Market, By Service

• Diagnostic Services
  • Lab Tests
  • Semen Analysis
  • Imaging
  • Diagnostic Procedure
• Treatment Services
  • Medications
  • Surgery
  • Intrauterine Insemination (IUI)
  • In Vitro Fertilization (IVF)
  • Intracytoplasmic Sperm Injection (ICSI)
  • Surrogacy
• Fertility Preservation
  • Egg Freezing
  • Embryo Freezing
  • Sperm Freezing
  • Amniotic Fluid Stem Cells
• Infertility Services Market, By Gender
  • Male
  • Female
• Infertility Services Market, By End-User
  • Hospitals
  • Fertility Clinics
  • Cyrobank
  • Research Centre